13F Pro

SEC Form 4 reporting owner

Sanders Corazon (Corsee) D.

Sanders Corazon (Corsee) D. has filed 9 Form 4 transactions reported between November 26, 2025 and August 17, 2026, as Director of Calidi Biotherapeutics, Inc., a reporting owner of Ultragenyx Pharmaceutical Inc. and Director of BeOne Medicines Ltd..

Name as filed: Sanders Corazon (Corsee) D.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.0M
4 lines
Companies
3
with Form 4 filings
Latest transaction
Aug 17, 2026
transaction date

Roles and reported holdings

  • CLDICalidi Biotherapeutics, Inc.
    Aug 17, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • RAREUltragenyx Pharmaceutical Inc.
    May 14, 2026 – Jun 15, 2026

    Reporting owner

    Held directly21,095 sh as of Jun 15, 2026 · Form 4

    24 months: $50K sold

  • ONCBeOne Medicines Ltd.
    Nov 26, 2025 – May 22, 2026

    Director

    Held directly0 sh as of May 22, 2026 · Form 4

    24 months: $961K sold

Transaction history

All 9 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 17, 2026CLDIDirectorGrant or awardCode A · direct6,000—Form 4
Jun 15, 2026RAREOpen-market saleCode S · direct2,000$50K@ $25.05Form 4
May 22, 2026ONCDirectorOpen-market saleCode S · direct212$66K@ $309.59Form 4
May 14, 2026RAREGrant or awardCode A · direct14,058—Form 4
May 14, 2026RAREGrant or awardCode A · direct7,751—Form 4
Nov 26, 2025ONCDirectorOption exerciseCode M · direct34,151—Form 4
Nov 26, 2025ONCDirectorOpen-market saleCode S · direct804$275K@ $342.47Form 4
Nov 26, 2025ONCDirectorOpen-market saleCode S · direct1,823$620K@ $340.20Form 4
Nov 26, 2025ONCDirectorOption exerciseCode M · direct2,627$418K@ $159.03Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.